Fountainhead AM LLC Buys 13,766 Shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Fountainhead AM LLC raised its holdings in shares of BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) by 41.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,649 shares of the company’s stock after acquiring an additional 13,766 shares during the period. Fountainhead AM LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $697,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Camelot Portfolios LLC grew its position in BlackRock Capital Allocation Term Trust by 4.3% during the fourth quarter. Camelot Portfolios LLC now owns 24,500 shares of the company’s stock valued at $366,000 after acquiring an additional 1,000 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in BlackRock Capital Allocation Term Trust by 6.8% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 25,074 shares of the company’s stock valued at $363,000 after acquiring an additional 1,589 shares during the last quarter. Claro Advisors LLC grew its position in BlackRock Capital Allocation Term Trust by 9.9% during the fourth quarter. Claro Advisors LLC now owns 17,736 shares of the company’s stock valued at $265,000 after acquiring an additional 1,603 shares during the last quarter. Sugarloaf Wealth Management LLC bought a new position in BlackRock Capital Allocation Term Trust during the fourth quarter valued at approximately $25,000. Finally, Consolidated Portfolio Review Corp grew its position in BlackRock Capital Allocation Term Trust by 2.3% during the fourth quarter. Consolidated Portfolio Review Corp now owns 89,622 shares of the company’s stock valued at $1,340,000 after acquiring an additional 2,017 shares during the last quarter. 36.12% of the stock is currently owned by institutional investors.

BlackRock Capital Allocation Term Trust Stock Up 1.0 %

NYSE BCAT traded up $0.15 on Tuesday, reaching $15.46. 151,668 shares of the company’s stock traded hands, compared to its average volume of 310,656. BlackRock Capital Allocation Term Trust has a 12 month low of $13.67 and a 12 month high of $16.82. The stock has a 50-day simple moving average of $15.79 and a 200 day simple moving average of $15.15.

BlackRock Capital Allocation Term Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be paid a $0.127 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 9.86%. The ex-dividend date is Friday, April 12th.

Insider Buying and Selling

In other news, major shareholder Saba Capital Management, L.P. acquired 14,936 shares of the stock in a transaction on Friday, January 26th. The stock was acquired at an average price of $15.40 per share, with a total value of $230,014.40. Following the completion of the transaction, the insider now owns 14,380,333 shares of the company’s stock, valued at approximately $221,457,128.20. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Insiders acquired 1,637,666 shares of company stock valued at $25,677,437 over the last quarter.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

See Also

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.